Health screening before a ceremony: what a good center asks
A long health questionnaire can feel intrusive, especially when you’re booking something you think of as spiritual. It is one of the best signs you’ll get about a center. Screening is how a center finds out, before anything is given, whether the ceremony could hurt you. A place that skips it is guessing.
This guide covers why screening matters, what a thorough process looks like, how to answer honestly, and what to make of it when a center says no. Our separate guide on medications and health conditions goes through the specific risks in more detail.
Why a center needs to know
The substances and practices used in ceremonies act on the body as well as the mind. Some raise heart rate and blood pressure. Some interact with common medicines. Some can bring on symptoms in people with a personal or family history of certain psychiatric conditions. A few examples from published research:
- Ayahuasca contains compounds that block an enzyme called monoamine oxidase. Researchers warned in 1998 that taking it with SSRI antidepressants could cause serotonin syndrome, with potentially grave results.
- In 62 online reports of people taking a classic psychedelic such as psilocybin or LSD while on lithium, 47% described a seizure.
- Ibogaine can prolong the QT interval, a measure of the heart’s electrical cycle, and deaths after taking it have been linked to heart problems people already had.
- Kambo can cause a racing heart and swings in blood pressure, and a 2025 review noted that pre-existing risk factors may make its rare fatal reactions worse.
None of these risks can be seen by looking at you. A center only knows about them if it asks.
How researchers screen
Clinical studies of psychedelics set a high bar. Safety guidelines published by Johns Hopkins researchers in 2008 describe a detailed medical history, a physical examination, an electrocardiogram (ECG) and blood and urine tests. Volunteers were excluded if their resting blood pressure was above 140/90, if they took certain medicines including lithium and some antidepressants, or if they or a close relative had a psychotic disorder or bipolar disorder. People who were pregnant were excluded too.
A ceremony center isn’t a research lab, and you shouldn’t expect blood tests before a cacao circle. The reasons behind those rules still apply wherever the same substances are used.
What good screening looks like
Oregon’s licensed psilocybin program gives a useful example of screening outside a lab. Before anyone takes part, a facilitator must hold a private preparation session and go through a client information form with them. The form asks, among other things:
- Whether you’ve taken lithium in the last 30 days.
- Whether you’re being treated for a medical or mental health condition.
- Whether you take any prescription or non-prescription medicines or supplements.
- Whether you’re having thoughts of harming yourself or others, or have a history of it.
- Whether you’ve ever been diagnosed with or treated for active psychosis.
- Whether you’re pregnant or breastfeeding.
Some answers rule a person out. Under the rules, someone who has taken lithium in the last 30 days, who has current thoughts of harming themselves or others, or who has been diagnosed with active psychosis can’t take part. Others lead to a conversation: a facilitator must encourage someone in treatment to talk to their health care provider, and must tell someone pregnant or breastfeeding that the risks are unknown.
Whatever kind of center you’re looking at, good screening tends to have these parts:
- A written form, sent before your place is confirmed and before you’ve paid in full.
- Questions about every medicine and supplement, your heart and blood pressure, seizures, and your mental health, including your family’s.
- A conversation with a real person who has read your answers and asks follow-up questions.
- Someone with medical training who reviews answers that raise concerns, or a clear rule for when the center asks for a letter from your doctor.
- A plain explanation of which conditions or medicines rule you out, and why.
- For each substance offered, its own screening. A form written for ayahuasca doesn’t cover kambo or 5-MeO-DMT.
- A check on arrival that nothing has changed since you filled in the form.
For ibogaine, expect more. A review of its effects on the heart concluded that it should only be given under strict medical observation with continuous heart monitoring. A center that offers ibogaine without an ECG beforehand and medical staff during the session is taking a risk with your life.
How common is careful screening?
A 2026 study in JAMA Network Open interviewed 49 organizations that advertise psychedelic retreats. All of them said they collected medical histories. About three-quarters excluded people with certain health conditions, most often psychosis, bipolar disorder or other mental illness, followed by heart conditions. The authors found wide differences between organizations in how these safeguards were put into practice.
So most places will hand you a form. What separates them is what happens next: who reads it, what they ask you, and whether they’re willing to act on what they find.
Answer honestly, even when it’s hard
It’s tempting to leave something off a form if you think it might get you turned away. Please don’t. The form is there to protect you, and the risks it asks about are real. If you hide a medicine, a diagnosis or a recent crisis, the people looking after you on the night won’t know what they’re dealing with if something goes wrong.
Some things are worth mentioning even if the form doesn’t ask:
- Medicines you take only now and then, such as migraine or sleep medicines.
- Supplements and herbal products.
- Alcohol and recreational drug use, including in the weeks before.
- A recent loss, breakup or crisis, even if you don’t think of it as a health matter.
- Any past bad reaction to a psychedelic or a ceremony.
- Heart symptoms you’ve never had checked, such as fainting, palpitations or chest pain on exertion.
If you’re worried about privacy, ask who will see your answers, how they’re stored and when they’re deleted. Oregon’s rules, for example, require client records to be kept at the service center and limit when they can be shared. Elsewhere you’ll have to ask.
When the answer is no
Being turned down is disappointing, especially if you’ve set your hopes on a particular retreat. It usually means the screening worked. A center that says no, or asks you to wait, or asks for a letter from your doctor, is taking your safety seriously.
Find out before you pay what happens to your money if screening rules you out. A fair center screens you before taking a large payment, or refunds you in full if it turns you down. A deposit that is lost either way gives the center a reason to say yes.
If you’re told no, ask why. Sometimes the reason is a medicine, and the answer is a conversation with your prescriber, not a different retreat. Never change or stop a prescribed medicine just to get through screening. Sometimes the reason is a condition that makes a particular substance risky for you, and a gentler practice such as breathwork, meditation or a sound bath might suit you better. Breathwork has its own health questions, so ask about those too.
Signs the screening is weak
- There’s no form, or it’s a few lines long.
- You can book and pay before anyone asks about your health.
- Nobody follows up on your answers.
- Nobody can tell you who reads the forms.
- The center has never turned anyone away.
- You’re told screening isn’t needed because “the medicine knows” or “the spirits choose who comes.”
- One form covers several different substances.
- Staff suggest leaving something off the form, or tell you a condition “won’t matter.”
Questions to ask about screening
- When will I get the health questionnaire, and who reads it?
- Does anyone with medical training review the answers?
- Which conditions and medicines rule someone out, and why?
- Do you screen separately for each substance you offer?
- Will you ask for a letter from my doctor in some cases?
- Have you ever turned someone away? What happened to their payment?
- Who will see my answers, and how are they stored?
More guides
- Medications and health conditions: who shouldn’t sit
- How to choose a ceremony center: a safety checklist
- Questions to ask before you book
- What a center’s emergency plan should cover
- Red flags: when to walk away
Reviews often show how seriously a center takes screening: whether someone called to go over a medicine, or whether the form was never mentioned again. You can search the Safe Ceremonies listings and read what past participants say, in categories such as ayahuasca, peyote and iboga and kambo.
Sources
- Johnson MW, Richards WA, Griffiths RR (2008). Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology. https://pmc.ncbi.nlm.nih.gov/articles/PMC3056407/
- Oregon Administrative Rules, Chapter 333, Division 333 (Psilocybin), including 333-333-5000 (preparation sessions), 333-333-5050 (client information form) and 333-333-4810 (client confidentiality). Checked 8 October 2026. https://secure.sos.state.or.us/oard/displayDivisionRules.action?selectedDivision=7102
- McGuire AL, Neitzke-Spruill L, Robinson JO, et al. (2026). Reported safety practices of publicly advertised psychedelic retreats. JAMA Network Open. https://pmc.ncbi.nlm.nih.gov/articles/PMC12780929/
- Callaway JC, Grob CS (1998). Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.1998.10399712
- Nayak SM, Gukasyan N, Barrett FS, et al. (2021). Seizures in online reports of classic psychedelics taken with lithium or lamotrigine. Pharmacopsychiatry, 54(5). https://doi.org/10.1055/a-1524-2794
- Koenig X, Hilber K (2015). The anti-addiction drug ibogaine and the heart: a delicate relation. Molecules. https://pmc.ncbi.nlm.nih.gov/articles/PMC4382526/
- Sacco MA, Gualtieri S, Spiliopoulou C, et al. (2025). Kambo administration and its association with sudden death: clinical and forensic perspectives from a systematic review. Cureus. https://pmc.ncbi.nlm.nih.gov/articles/PMC11833272/
Photo: Pen on a notebook by Thomas Martinsen faceline, CC0 1.0.
